To investigate the presence of ongoing immune activation following recovery from COVID-19, we assessed the phenotype and activation/proliferation profiles of conventional CD4+ and CD8+ T-cells, TCR-γδ T, NK, B-cells, and monocytes by flow cytometry in PBMC samples from 63 patients at 3 months post admission. This evidence concerns the gene CD4 and COVID-19.